Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 162

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

In Vivo Effects of Mesenchymal Stromal Cells in Two Patients With Severe Acute Respiratory Distress Syndrome

Open access
Simonson, Oscar E., Mougiakakos, Dimitrios, Heldring, Nina, Bassi, Giulio, Johansson, Henrik J., Dalén, Magnus, Jitschin, Regina, Rodin, Sergey, Corbascio, Matthias, El Andaloussi, Samir, Wiklander, Oscar P.B., Nordin, Joel Z., Skog, Johan, Romain, Charlotte, Koestler, Tina, Hellgren-Johansson, Laila, Schiller, Petter, Joachimsson, Per-Olof, Hägglund, Hans, Mattsson, Mattias, Lehtiö, Janne, Faridani, Omid R., Sandberg, Rickard, Korsgren, Olle, Krampera, Mauro, Weiss, Daniel J., Grinnemo, Karl-Henrik, Le Blanc, Katarina·2015·Stem Cells Translational Medicine

Abstract

Mesenchymal stromal cells (MSCs) have been investigated as a treatment for various inflammatory diseases because of their immunomodulatory and reparative properties. However, many basic questions concerning their mechanisms of action after systemic infusion remain unanswered. We performed a detailed analysis of the immunomodulatory properties and proteomic profile of MSCs systemically administered to two patients with severe refractory acute respiratory distress syndrome (ARDS) on a compassionate use basis and attempted to correlate these with in vivo anti-inflammatory actions. Both patients received 2 × 106 cells per kilogram, and each subsequently improved with resolution of respiratory, hemodynamic, and multiorgan failure. In parallel, a decrease was seen in multiple pulmonary and systemic markers of inflammation, including epithelial apoptosis, alveolar-capillary fluid leakage, and proinflammatory cytokines, microRNAs, and chemokines. In vitro studies of the MSCs demonstrated a broad anti-inflammatory capacity, including suppression of T-cell responses and induction of regulatory phenotypes in T cells, monocytes, and neutrophils. Some of these in vitro potency assessments correlated with, and were relevant to, the observed in vivo actions. These experiences highlight both the mechanistic information that can be gained from clinical experience and the value of correlating in vitro potency assessments with clinical effects. The findings also suggest, but do not prove, a beneficial effect of lung protective strategies using adoptively transferred MSCs in ARDS. Appropriate randomized clinical trials are required to further assess any potential clinical efficacy and investigate the effects on in vivo inflammation. Significance: This article describes the cases of two patients with severe refractory adult respiratory syndrome (ARDS) who failed to improve after both standard life support measures, including mechanical ventilation, and additional measures, including extracorporeal ventilation (i.e., in a heart-lung machine). Unlike acute forms of ARDS (such in the current NIH-sponsored study of mesenchymal stromal cells in ARDS), recovery does not generally occur in such patients.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.5966/sctm.2015-0021

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 162

Metadata

Authors
Simonson, O. E., Mougiakakos, D., Heldring, N., Bassi, G., Johansson, H. J., Dalén, M., Jitschin, R., Rodin, S., Corbascio, M., El Andaloussi, S., Wiklander, O. P. B., Nordin, J. Z., Skog, J., Romain, C., Koestler, T., Hellgren-Johansson, L., Schiller, P., Joachimsson, P.-O., Hägglund, H., Mattsson, M., Lehtiö, J., Faridani, O. R., Sandberg, R., Korsgren, O., Krampera, M., Weiss, D. J., Grinnemo, K.-H., & Le Blanc, K.
Venue
Stem Cells Translational Medicine
Published
2015-08-18
Volume
4
Issue
10
Pages
1199-1213
ISSN
  • 2157-6564 (ISSN-L)
  • 2157-6580
OpenAlex
W2146354741
Cited by
162
References
1
FWCI
5.54
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: In Vivo Effects of Mesenchymal Stromal Cells in Two Patients With Severe Acute Respiratory Distress Syndrome. https://app.cochat.ai/papers/10.5966/sctm.2015-0021
The paper
Simonson, O. E., Mougiakakos, D., Heldring, N., Bassi, G., Johansson, H. J., Dalén, M., Jitschin, R., Rodin, S., Corbascio, M., El Andaloussi, S., Wiklander, O. P. B., Nordin, J. Z., Skog, J., Romain, C., Koestler, T., Hellgren-Johansson, L., Schiller, P., Joachimsson, P.-O., Hägglund, H., . . . Le Blanc, K. (2015). In Vivo Effects of Mesenchymal Stromal Cells in Two Patients With Severe Acute Respiratory Distress Syndrome. Stem Cells Translational Medicine. https://doi.org/10.5966/sctm.2015-0021

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.